<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37203937</PMID><DateCompleted><Year>2023</Year><Month>05</Month><Day>22</Day></DateCompleted><DateRevised><Year>2023</Year><Month>06</Month><Day>02</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1815-672X</ISSN><JournalIssue CitedMedium="Internet"><Volume>61</Volume><Issue>259</Issue><PubDate><Year>2023</Year><Month>Mar</Month><Day>01</Day></PubDate></JournalIssue><Title>JNMA; journal of the Nepal Medical Association</Title><ISOAbbreviation>JNMA J Nepal Med Assoc</ISOAbbreviation></Journal><ArticleTitle>Bulbar Onset Amyotrophic Lateral Sclerosis: A Case Report.</ArticleTitle><Pagination><StartPage>271</StartPage><EndPage>273</EndPage><MedlinePgn>271-273</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.31729/jnma.8098</ELocationID><Abstract><AbstractText Label="UNLABELLED">Amyotrophic lateral sclerosis is a rare, progressive, incurable neurodegenerative disorder that affects motor neurons leading to progressive muscle weakness, disability, and eventually death. A 45-year-old male, initially presented with hoarseness, flickering of tongue, and intermittent aspirations. In course of three years, patient developed motor aphasia, frequent aspirations and an inability to hold his neck. Patient was diagnosed with a bulbar onset type of amyotrophic lateral sclerosis on the basis of neurodegenerative features with normal radiographic imaging. For the prevention of recurrent aspiration pneumonia, he was managed with a percutaneous endoscopic gastrostomy tube. As he started developing respiratory failure tracheostomy was performed and kept on a continuous bi-level positive airway pressure ventilator, in the meantime, two courses of injection Edaravone were given. Early evaluation, diagnosis and management of the condition is a cornerstone for better prognosis of disease and survival.</AbstractText><AbstractText Label="KEYWORDS" NlmCategory="UNASSIGNED">amyotrophic lateral sclerosis; aspiration pneumonia; case reports; edaravone.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Rai</LastName><ForeName>Kabindra</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>KIST Medical College and Teaching Hospital, Mahalaxmi, Lalitpur, Nepal.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rai</LastName><ForeName>Nilshan</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>KIST Medical College and Teaching Hospital, Mahalaxmi, Lalitpur, Nepal.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chhantel Thapa</LastName><ForeName>Milan Kumar</ForeName><Initials>MK</Initials><AffiliationInfo><Affiliation>KIST Medical College and Teaching Hospital, Mahalaxmi, Lalitpur, Nepal.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shrestha</LastName><ForeName>Rajan</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>KIST Medical College and Teaching Hospital, Mahalaxmi, Lalitpur, Nepal.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Singh</LastName><ForeName>Sampurna</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>KIST Medical College and Teaching Hospital, Mahalaxmi, Lalitpur, Nepal.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Thapa</LastName><ForeName>Monika</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Neurology, National Neuro Center, Maharajgunj, Kathmandu, Nepal.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D002363">Case Reports</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>03</Month><Day>01</Day></ArticleDate></Article><MedlineJournalInfo><Country>Nepal</Country><MedlineTA>JNMA J Nepal Med Assoc</MedlineTA><NlmUniqueID>0045233</NlmUniqueID><ISSNLinking>0028-2715</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>S798V6YJRP</RegistryNumber><NameOfSubstance UI="D000077553">Edaravone</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000077553" MajorTopicYN="N">Edaravone</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012131" MajorTopicYN="Y">Respiratory Insufficiency</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011379" MajorTopicYN="N">Prognosis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014139" MajorTopicYN="N">Tracheostomy</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading></MeshHeadingList><CoiStatement>
<b>None.</b>
</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>2</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>5</Month><Day>22</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>5</Month><Day>19</Day><Hour>13</Hour><Minute>5</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>5</Month><Day>19</Day><Hour>6</Hour><Minute>23</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37203937</ArticleId><ArticleId IdType="pmc">PMC10231545</ArticleId><ArticleId IdType="doi">10.31729/jnma.8098</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Masrori P, Van Damme P. European Journal of Neurology. Vol. 27. Blackwell Publishing Ltd; 2020. Amyotrophic lateral sclerosis: a clinical review. pp. 1918&#x2013;29.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ene.14393</ArticleId><ArticleId IdType="pmc">PMC7540334</ArticleId><ArticleId IdType="pubmed">32526057</ArticleId></ArticleIdList></Reference><Reference><Citation>Brown RH, Al-Chalabi A. Amyotrophic lateral sclerosis. N Engl J Med. 2017 Jul 13;377(2):162&#x2013;72. doi: 10.1056/NEJMra1603471.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMra1603471</ArticleId><ArticleId IdType="pubmed">28700839</ArticleId></ArticleIdList></Reference><Reference><Citation>Wales S, C Kiernan DSc AM, Cheah MBiostat BC, Burrell MBBS J, Zoing BNurs MC, Kiernan MC, et al. Seminar amyotrophic lateral sclerosis. Lancet. 2011 Feb 11;377:942&#x2013;55. doi: 10.1016/S0140-6736(10)61156-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(10)61156-7</ArticleId><ArticleId IdType="pubmed">21296405</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu L, Liu T, Liu L, Yao X, Chen L, Fan D, et al. Global variation in prevalence and incidence of amyotrophic lateral sclerosis: a systematic review and meta-analysis. J Neurol. 2020 Apr;267(4):944&#x2013;53. doi: 10.1007/s00415-019-09652-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-019-09652-y</ArticleId><ArticleId IdType="pubmed">31797084</ArticleId></ArticleIdList></Reference><Reference><Citation>Wijesekera LC, Leigh PN. Amyotrophic lateral sclerosis. Orphanet J Rare Dis. 2009 Feb 3;4:3. doi: 10.1186/1750-1172-4-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1750-1172-4-3</ArticleId><ArticleId IdType="pmc">PMC2656493</ArticleId><ArticleId IdType="pubmed">19192301</ArticleId></ArticleIdList></Reference><Reference><Citation>Gittings LM, Sattler R. Recent advances in understanding amyotrophic lateral sclerosis and emerging therapies. Fac Rev. 2020;9:12. doi: 10.12703/b/9-12.</Citation><ArticleIdList><ArticleId IdType="doi">10.12703/b/9-12</ArticleId><ArticleId IdType="pmc">PMC7886072</ArticleId><ArticleId IdType="pubmed">33659944</ArticleId></ArticleIdList></Reference><Reference><Citation>Cho H, Shukla S. Role of Edaravone as a treatment option for patients with amyotrophic lateral sclerosis. Pharmaceuticals (Basel). 2020 Dec 31;14(1):29. doi: 10.3390/ph14010029.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ph14010029</ArticleId><ArticleId IdType="pmc">PMC7823603</ArticleId><ArticleId IdType="pubmed">33396271</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>